Endonovo Therapeutics Company Description
Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine.
The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema.
Its Electroceuticals medical device is also used for the treatment of cardiovascular diseases, chronic kidney, liver diseases, non-alcoholic steatohepatitis, cardiovascular and peripheral artery diseases, and ischemic stroke, as well as for central nervous system disorders, such as traumatic brain injury, acute concussions, post-concussion syndrome, stroke, and multiple sclerosis.
Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.
| Country | United States |
| Founded | 2008 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 1 |
| CEO | Alan Collier |
Contact Details
Address: 6320 Canoga Avenue Woodland Hills, Delaware 91367 United States | |
| Phone | 800 489 4774 |
| Website | endonovo.com |
Stock Details
| Ticker Symbol | ENDV |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US29272H3003 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Alan Brian Collier | Chairman and Chief Executive Officer |
| Don Calabria | Vice President of Operations |
| Garry Michael Kann | Head of Corporate Development |
| Ira Weisberg | President and Chief Commercial Officer of Medical Division |